|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation显示文摘Liver transplantation(LT)is the best treatment for endstage hepatic failure,with an excellent survival rates over the last decade.Biliary complications after LT pose a major challenge especially with the increasing number of procured organs after circulatory death.Ischaemic cholangiopathy(IC)is a set of disorders characterized by multiple diffuse strictures affecting the graft biliary system in the absence of hepatic artery thrombosis or stenosis.It commonly presents with cholestasis and cholangitis resulting in higher readmission rates,longer length of stay,repeated therapeutic interventions,and eventually re-transplantation with consequent effects on the patient’s quality of life and increased health care costs.The pathogenesis of IC is unclear and exhibits a higher prevalence with prolonged ischaemia time,donation after circulatory death(DCD),rejection,and cytomegalovirus infection.The majority of IC occurs within 12 mo after LT.Prolonged warm ischaemic times predispose to a profound injury with a subsequently higher prevalence of IC.Biliary complications and IC rates are between 16%and 29%in DCD grafts com-pared to between 3%and 17%in donation after brain death(DBD)grafts.The majority of ischaemic biliary lesions occur within 30 d in DCD compared to 90 d in DBD grafts following transplantation.However,there are many other risk factors for IC that should be considered.The benefits of DCD in expanding the donor pool are hindered by the higher incidence of IC with increased rates of re-transplantation.Careful donor selection and procurement might help to optimize the utilization of DCD grafts. | Moustafa Mabrouk Mourad Abdullah Algarni Christos Liossis Simon R Bramhall | 2014 | World Journal of Gastroenterology2014，20，20： | 16 |
| 2 | Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus 显示文摘 | Katsiari CG Liossis SN Souliotis VL | 2002 | Clinical Immunology2002，103，1： | 1 |
| 3 | Evidence that DKK-l is dysfunctional in ankylosing spondylitis显示文摘 | Daoussis D Liossis SN Solomou EE et a1 | 2010 | Arthritis Rheum2010，62，1： | 1 |
| 4 | Targeting CD40L:a promising therapeutic approach显示文摘 | Daoussis D Andonopoulos A P Liossis S N | 2004 | Clin Diagn Lab Immunol2004，11，4： | 1 |
| 5 | Pathogenesis of human systemic lupus erythematosus: recent advances 显示文摘 | Crispin JC Liossis SN Kis-Toth K | 2010 | Trends Mol Med2010，16，2： | 1 |
| 6 | Evidence that Dkk 1 is dysfunctional in ankylosing spondylitis 显示文摘 | Daoussis D Liossis SNC Solomou EE | 2010 | Arthritis Rheum2010，62，1： | 1 |
| 7 | The aeute effeet of upper-body complex training on power output of martial art athletes as measured by the bench press throw exercise显示文摘 | LIOSSIS L D FORSYTH J LIOSSIS C et a l | 2013 | J Human Kinetics2013，39，1： | 1 |
| 8 | The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: A reappraisal 显示文摘 | Katsiari C G Liossis S N Sfikakis P P | 2009 | Seminars in Arthrifts and Rheumatism2009，1，14： | 1 |
| 9 | Monoclonal antibodies and fusion proteins in medicine显示文摘 | Liossis SN Tsokos GC | 2005 | J Allergy Clin Immunol2005，116，4： | 1 |
| 10 | Pathogenesis of human systemic lupus erythematosus: recent advances 显示文摘 | Crispin JC Liossis S Kis-Toth K | 2010 | Trends MolMed2010，16，2： | 1 |
| 11 | Monoclonal antibodies and fusion proteins in medicine显示文摘 | Liossis S N Tsokos G C | 2005 | J Allergy Clin Immunol2005，116，： | 1 |
| 12 | Telomerase expression as a marker in prostate cancer:correlation to clinicopathologic predictors显示文摘 | Athanassiadou P Bantis A Gonidi M Liossi A Aggelonidou E Petrakakou E | 2003 | J Exp Clin Cancer Res2003，22，： | 1 |
| 13 | Comparison of risks from percutaneous central venous catheters and peripheral lines in infants of extremely low birth weight: a eohort eontrolled study of infants显示文摘 | Liossis G Bardin C Papageorgiou A | 2003 | J Matern Fetal Neonatal Med2003，13，3： | 1 |
| 14 | Experience with rituximab in scleroderma:results from a 1-year,proof-ofprinciple study显示文摘 | Daoussis D Liossis SN Tsamandas AC | 2010 | Rheumatology (Oxford)2010，49，2： | 1 |
| 15 | Overexpression of the heat shock protein 70 enhances the TCR/CD3- and Fas/Apo-1/ CD95-mediated apoptotic cell death in Jurkat T cells 显示文摘 | Liossis S N Ding X Z Kiang J G | 1997 | J Immunol1997，158，12： | 1 |
| 16 | Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus显示文摘 | KATSIARI C G LIOSSIS S N SOULIOTIS V L | 2002 | Clin Immunol2002，103，1： | 1 |
| 17 | The Promoting Adult Resilience (PAR) Program:The Effectiveness of the Second,Shorter Pilot of a Workplace Prevention Program显示文摘 | Liossis P.L I.M.Shochet P.M.Millear H.Biggs | | 0，，02： | 1 |
| 18 | Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis显示文摘 | Daoussis D Liossis SN Solomou EE | 2010 | Arthritis Rheum2010，62，1： | 1 |
| 19 | Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis显示文摘 | Daoussis D Liossis S N Solomou E E | | 0，，01： | 1 |
| 20 | Helping parents to help their child with pro- cedural and everyday pain:practical,evidence-based advice显示文摘 | Power N Liossi C Franek L | 2007 | J SpecPediatr Nurs2007，12，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员